AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

The Effects of Xuezhikang and Atorvastatin on Lipid in Patients With Dyslipidemia and Prediabetes

RecruitingPhase 4Ages 18 Years - anyAllBeijing Tsinghua Chang Gung Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study compares the impact of Xuezhikang and atorvastatin on glucose metabolism to explore the incidence of prediabetes patients developing diabetes after 24 weeks of Xuezhikang use, and by investigating the effect of Xuezhikang on blood glucose fluctuations, discusses the possible mechanisms by which Xuezhikang affects glucose metabolism.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Age โ‰ฅ 18 years old; * No gender restrictions; * Definition of pre diabetes: All subjects were tested with 75g OGTT to measure fasting and 2h venous serum glucose and glycosylated hemoglobin. Fasting blood glucose โ‰ฅ 6.1 and \< 7mmol/L, 2-hour serum glucose โ‰ฅ 7.8 and \< 11.1mmol/L after glucose load, and glycated hemoglobin\<6.5%; * Abnormal lipid metabolism: LDL-c โ‰ฅ 3.4 mmol/L and\<4.9 mmol/L, and TG โ‰ค 5.6 mmol/L; (2) Non-HDL-c โ‰ฅ 4.1mmol/L and\<5.7 mmol/L, and TG โ‰ค 5.6 mmol/L; * Voluntarily sign the informed consent form. Exclusion Criteria: * Patients who have met the diagnosis of diabetes; * Within 3 months prior to signing the informed consent form, there was an acute coronary syndrome, stroke, or transient ischemic attack. * ALT/AST\>3 times ULN; * Known myopathy, rhabdomyolysis, or creatine kinase levels greater than 4-fold ULN, and not caused by muscle injury; * Pregnant or planning to conceive; * Have used any lipid-lowering drugs within 3 months; * Individuals with allergies/contraindications to Xuezhikang and Atorvastatin. * Suffering from any of the following diseases: uncontrolled hyperthyroidism and hypothyroidism, severe heart failure, malignant tumors, hematopoietic system diseases, digestive system diseases affecting digestion and/or absorption function, mental disorders, other serious or unstable physical diseases. * History of alcohol or drug abuse or dependence within 3 months prior to joining the trial. * Participated in clinical trials of other drugs or devices within 3 months prior to joining the trial. * Researchers believe that other situations are not suitable for participating in the experiment.
๐Ÿ’Š

What it tests

  • Xuezhikang
  • Atorvastatin
๐Ÿ“

Where

3 sites
Beiqijia Community Health Service Center, Changping District, Beijing
Beijing, China
Beijing Tsinghua Changgung Hospital
Beijing, China
Xiaotangshan Community Health Service Center, Changping District, Beijing
Beijing, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy